1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.4 MARKETS COVERED 18
1.5 YEARS CONSIDERED FOR THE STUDY 18
1.6 CURRENCY 19
1.7 STAKEHOLDERS 19
1.8 LIMITATIONS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH APPROACH 20
2.1.1 SECONDARY RESEARCH 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 22
2.1.2.1 Key data from primary sources 22
2.1.2.2 Breakdown of primaries 23
2.1.2.3 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1 BOTTOM-UP APPROACH 24
2.2.2 TOP-DOWN APPROACH 26
2.3 DATA TRIANGULATION APPROACH 26
2.4 MARKET RANKING ANALYSIS 27
2.5 ASSUMPTIONS FOR THE STUDY 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 32
4.1 ATP ASSAYS: MARKET OVERVIEW 32
4.2 ATP ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 33
4.3 REGIONAL MIX: ATP ASSAYS MARKET 34
4.4 ATP ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS 34
?

5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 35
5.2.1.1 Growing demand for ATP assays in pharmaceutical & biotechnology companies 35
5.2.1.2 Rising investments in pharmaceutical & biotechnology R&D 36
5.2.1.3 Increasing prevalence of cancer 36
5.2.1.4 Shift from culture-based tests to rapid tests 37
5.2.1.5 Rising incidence and prevalence of chronic & infectious diseases 38
5.2.2 RESTRAINTS 39
5.2.2.1 High cost of instruments 39
5.2.3 OPPORTUNITIES 40
5.2.3.1 Technology enhancements in ATP assay probes 40
5.2.3.2 Growth prospects in emerging markets 40

6 ATP ASSAYS MARKET, BY PRODUCT 41
6.1 INTRODUCTION 42
6.2 CONSUMABLES & ACCESSORIES 43
6.2.1 REAGENTS & KITS 44
6.2.1.1 Wide applications of reagents & kits account for the large share of this segment 44
6.2.2 MICROPLATES 46
6.2.2.1 As miniaturization of microplates provides high utility over gel-based well systems, their adoption is high in the analytical and life science industry 46
6.2.3 OTHER CONSUMABLES & ACCESSORIES 47
6.3 INSTRUMENTS 48
6.3.1 LUMINOMETERS 49
6.3.1.1 Luminometers are comparatively low-priced and therefore widely adopted 49
6.3.2 SPECTROPHOTOMETERS 51
6.3.2.1 Spectrophotometers are costlier than luminometers and, therefore, less-preferred by end users in the ATP assays market 51

7 ATP ASSAYS MARKET, BY APPLICATION 52
7.1 INTRODUCTION 53
7.2 CONTAMINATION TESTING 54
7.2.1 NEED TO MEET REGULATORY MANDATES FOR CONTAMINATION AND QUALITY TESTING IS A KEY DRIVER OF MARKET GROWTH 54
7.3 DISEASE TESTING 55
7.3.1 GROWING DISEASE INCIDENCE AND RISING AWARENESS ARE EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD 55
?
7.4 DRUG DISCOVERY & DEVELOPMENT 56
7.4.1 INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS WILL DRIVE MARKET GROWTH 56

8 ATP ASSAYS MARKET, BY END USER 58
8.1 INTRODUCTION 59
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 60
8.2.1 GROWTH IN DRUG R&D PIPELINES TO INCREASE THE FOCUS OF PHARMA & BIOTECH COMPANIES ON QUALITY CONTROL MEASURES?DRIVING GROWTH IN THE ATP ASSAYS MARKET 60
8.3 FOOD & BEVERAGE INDUSTRY 61
8.3.1 INCIDENTS OF FOOD CONTAMINATION HAVE LED TO THE INTRODUCTION OF NEW LEGISLATIONS FOR FOOD SAFETY TESTING, THEREBY DRIVING THE GROWTH OF THE ATP ASSAYS MARKET 61
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES 62
8.4.1 GROWING DEMAND FOR EARLY DIAGNOSIS OF DISEASES IS A MAJOR FACTOR DRIVING THE ADOPTION OF ATP ASSAYS 62
8.5 ACADEMIC & RESEARCH INSTITUTIONS 63
8.5.1 ATP ASSAYS ARE USED FOR RESEARCH ACTIVITIES RELATED TO THE GROWTH RATE & VIABILITY OF MICROORGANISMS 63

9 ATP ASSAYS MARKET, BY REGION 65
9.1 INTRODUCTION 66
9.2 NORTH AMERICA 67
9.2.1 US 70
9.2.1.1 US to dominate the North American ATP assays market 70
9.2.2 CANADA 73
9.2.2.1 Availability of a broad range of government funding programs to support life science research to drive market growth 73
9.3 EUROPE 75
9.3.1 GERMANY 79
9.3.1.1 Demand for ATP assays will be driven by the large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers 79
9.3.2 FRANCE 81
9.3.2.1 Strong agro-food sector and a major focus on biotechnology R&D to drive market growth in France 81
9.3.3 UK 83
9.3.3.1 UK has the largest pharmaceutical R&D expenditure in Europe 83
9.3.4 ITALY 85
9.3.4.1 High cancer burden to increase the demand for ATP assays in Italy 85
9.3.5 SPAIN 87
9.3.5.1 Growth in the personalized medicine sector and clinical diagnostics market to drive the ATP assays market in Spain 87
9.3.6 REST OF EUROPE 89
?
9.4 ASIA PACIFIC 91
9.4.1 JAPAN 95
9.4.1.1 High incidence of cancer to increase the demand for ATP assays in Japan 95
9.4.2 CHINA 97
9.4.2.1 Increasing pharmaceutical R&D investments in the country to support market growth 97
9.4.3 INDIA 99
9.4.3.1 Growing adoption of ATP assay techniques in research and clinical applications to drive market growth in India 99
9.4.4 REST OF ASIA PACIFIC 101
9.5 LATIN AMERICA 103
9.6 MIDDLE EAST & AFRICA 105

10 COMPETITIVE LANDSCAPE 108
10.1 INTRODUCTION 108
10.2 MARKET RANKING FOR KEY PLAYERS IN THE ATP ASSAYS MARKET 109
10.3 COMPETITIVE LEADERSHIP MAPPING 109
10.3.1 VISIONARY LEADERS 109
10.3.2 INNOVATORS 110
10.3.3 DYNAMIC DIFFERENTIATORS 110
10.3.4 EMERGING COMPANIES 110
10.4 COMPETITIVE SITUATIONS AND TRENDS 112
10.5 COMPETITIVE ASSESSMENT OF R&D EXPENDITURE 116
10.6 PRODUCT PORTFOLIO ANALYSIS 117

11 COMPANY PROFILES 118
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 THERMO FISHER SCIENTIFIC, INC. 118
11.2 PROMEGA CORPORATION 121
11.3 MERCK KGAA 123
11.4 PERKINELMER, INC. 126
11.5 AGILENT TECHNOLOGIES, INC. 130
11.6 ABCAM PLC. 133
11.7 LONZA GROUP 135
11.8 NEOGEN CORPORATION 137
11.9 3M COMPANY 139
11.10 DANAHER CORPORATION 141
11.11 PROMOCELL GMBH 143
11.12 GENO TECHNOLOGY, INC. 144
11.13 ABNOVA CORPORATION 145
11.14 AAT BIOQUEST, INC. 146
11.15 BIOTHEMA AB 147
11.16 BIOVISION, INC. 148
11.17 HYGIENA, LLC. 149
11.18 BIOTIUM 151
11.19 CREATIVE BIOARRAY 152
11.20 CANVAX BIOTECH S.L. 153
11.21 ELABSCIENCE 154
11.22 MBL INTERNATIONAL CORPORATION (A SUBSIDIARY OF JSR CORPORATION) 155
11.23 RUHOF CORPORATION 156
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX 157
12.1 DISCUSSION GUIDE 157
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 161
12.3 AVAILABLE CUSTOMIZATIONS 163
12.4 RELATED REPORTS 163
12.5 AUTHOR DETAILS 164